Search

Your search keyword '"Worm, Margitta"' showing total 65 results

Search Constraints

Start Over You searched for: Author "Worm, Margitta" Remove constraint Author: "Worm, Margitta" Journal journal der deutschen dermatologischen gesellschaft journal of the german society of dermatology jddg Remove constraint Journal: journal der deutschen dermatologischen gesellschaft journal of the german society of dermatology jddg
65 results on '"Worm, Margitta"'

Search Results

1. Frequency and diagnostic findings of type I and type IV reactions to beta-lactam antibiotics - significance of the time interval between clinical reaction and skin testing.

2. S2k guideline: Diagnosis and therapy of localized scleroderma.

3. S3 guideline Atopic dermatitis: Part 2 - Systemic treatment.

4. S3 Guideline Atopic dermatitis: Part 1 - General aspects, topical and non-drug therapies, special patient groups.

5. Juckreiz, Schlafstörungen, depressive Symptome, Fatigue und Einschränkungen der Arbeitsproduktivität bei Patienten mit moderater bis schwerer atopischer Dermatitis: Daten aus dem TREATgermany-Register.

6. Itch, sleep loss, depressive symptoms, fatigue, and productivity loss in patients with moderate-to-severe atopic dermatitis: Analyses of TREATgermany registry data.

7. S2k guideline diagnosis, prevention, and therapy of hand eczema.

10. Current situation of allergological health care at German hospitals.

11. S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid.

14. German S1 guideline: Contact dermatitis.

18. Perception of the coronavirus pandemic by patients with atopic dermatitis - Results from the TREATgermany registry.

19. Tralokinumab in atopic dermatitis.

21. S2k guideline: Diagnosis and management of cutaneous lupus erythematosus - Part 2: Therapy, risk factors and other special topics.

24. S2k guideline: Diagnosis and management of cutaneous lupus erythematosus - Part 1: Classification, diagnosis, prevention, activity scores.

26. Atopic skin diathesis rather than atopic dermatitis is associated with specific contact allergies.

27. Update "Systemic treatment of atopic dermatitis" of the S2k-guideline on atopic dermatitis.

30. Modern therapies in atopic dermatitis: biologics and small molecule drugs.

32. COVID-19 and implications for dermatological and allergological diseases.

35. S3 Guidelines: Epicutaneous patch testing with contact allergens and drugs - Short version, Part 2.

38. S3 guidelines: Epicutaneous patch testing with contact allergens and drugs - Short version, Part 1.

39. Wissensstand zur Anaphylaxie und Umgang mit Adrenalinautoinjektoren in Apotheken.

40. Level of knowledge among pharmacists regarding anaphylaxis and the use of epinephrine autoinjectors.

41. Guidelines on dermatomyositis--excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology.

42. German guidelines for the diagnosis and therapy of localized scleroderma.

43. [Not Available].

44. S2k guideline on diagnosis and treatment of atopic dermatitis--short version.

45. S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid.

46. S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid.

47. The allergic emergency--management of severe allergic reactions.

48. Prevalence and treatment profile of patients with grass pollen and house dust mite allergy.

49. Influence of bosentan on fingertip rewarming in patients with systemic sclerosis.

50. Causes and risk factors for anaphylaxis.

Catalog

Books, media, physical & digital resources